Back

Gender differences in in-hospital outcome of patients with acute myocardial infarction undergoing percutaneous coronary intervention in Kosovo

22 May 2023 (12:12 - 13:48)
Organised by: Logo
Congress Presentation Part of: ePosters in CAD - CCS - ACS 5 Revascularisation HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speakers

Photo
Professor Shpend Elezi

University Clinical Centre of Kosova, Pristina (Kosovo Republic of)

Photo
Professor Gani Bajraktari

University of Prishtina, Pristina (Kosovo Republic of)

4 More presentations in this session

Presentation thumbnail
Risk assessment and clinical outcome for CABG in patients with coronary artery disease and severely impaired left ventricular ejection fraction
Professor F. Schoenrath (Berlin, DE)
Abstract Slides
Presentation thumbnail
Predictive value of NT-proBNP on long term MACE in STEMI patients
Associate Professor A. Bakalli (Pristina, XK)
Abstract Slides
Presentation thumbnail
Predictors of in-hospital mortality of patients with acute myocardial infarction in Kosovo
Professor G. Bajraktari (Pristina, XK)
Abstract Slides
Presentation thumbnail
Mineralocorticoid receptor antagonists after acute myocardial infarction in patients with mild to moderately reduced ejection fraction
Doctor C. Carvalho (Viana do Castelo, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in CAD - CCS - ACS 5

The Event

Event poster

Heart Failure 2023

22 May 2023 12:12 CET
You may be interested in
thumbnail
Congress Presentation
Gender differences in in-hospital management of patients with acute myocardial infarction in Kosovo
21 May 2023
thumbnail
Congress Presentation
Outcomes following percutaneous coronary intervention in a tertiary cardiac centre in the UK
15 March 2025
thumbnail
Congress Presentation
Increased in-hospital complication risk in women undergoing chronic total occlusion recanalization
27 August 2023
thumbnail
Congress Presentation
Early outcome in patients with STEMI undergoing primary PCI and high Zwolle risk score discharged within 72 hours
8 March 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources